This result indicates that WHSC1L1-mediated K721 mono-methylation of EGFR induces resistance to erlotinib and that knockdown of WHSC1L1 is likely to sensitize SCCHN cells to EGFR inhibition. The gene discussed is NSD3; the disease is head and neck squamous cell carcinoma.